NAVIPP Scientific Watch Serie
A deadly virus
Nipah virus is one of the deadliest pathogens known, with mortality rates up to 75%. It has caused repeated outbreaks in South Asia, raising global concern due to its potential for person-to-person transmission.
What recent research shows
New studies suggest that aerosol transmission, while rare, may play a role in Nipah’s spread. At the same time, breakthroughs in antibody-based treatments offer hope: dual-target antibodies have shown protection in animal models even after infection has begun.
Why this matters for preparedness
These findings illustrate both the danger and the opportunity. Nipah’s transmission routes are not fully understood, making vigilance essential. At the same time, antibody innovations show that treatments can be developed even for the most challenging pathogens.
The NAVIPP approach
NAVIPP complements these advances by focusing on small-molecule antivirals with broad-spectrum activity. By building a pipeline that includes compounds, antibodies, and innovative delivery systems, we strengthen Europe’s ability to respond rapidly when Nipah or similar threats emerge.
Conclusion
Nipah virus remains a top pandemic concern, but science is moving fast. Preparedness means combining surveillance, innovation, and coordinated response — exactly what NAVIPP is designed to deliver.